Table 2 Clinical T and N staging of patients with basaloid and non-basaloid SCCs.
Staging | Basaloid (n = 39) | Non-basaloid (n = 161) | p value |
|---|---|---|---|
cT stage | 0.418 | ||
T1a | 1 (2.6) | 1 (0.6) | |
T1b | 8 (20.5) | 20 (12.4) | |
T1c | 5 (12.8) | 31 (19.3) | |
T2a | 12 (30.8) | 44 (27.3) | |
T2b | 5 (12.8) | 15 (9.3) | |
T3 | 4 (10.3) | 35 (21.7) | |
T4 | 4 (10.3) | 15 (9.3) | |
cN stage | 0.818 | ||
N0 | 30 (76.9) | 123 (76.4) | |
N1 | 6 (15.4) | 22 (13.7) | |
N2 | 2 (5.1) | 4 (2.5) | |
N3 | 1 (2.6) | 2 (1.2) |